ATR signaling mediates an S-phase checkpoint after inhibition of poly(ADP-ribose) polymerase activity

Human fibroblasts, capable of expressing a kinase-dead form of ATR (ATRkd), can be sensitized to the cytotoxic effects of methyl methanesulfonate (MMS) by the PARP inhibitor 4-amino-1,8-naphthalimide (4-AN). The combination of MMS + 4-AN results in accumulation of cells in S-phase of the cell cycle...

Full description

Saved in:
Bibliographic Details
Published inDNA repair Vol. 6; no. 6; pp. 742 - 750
Main Authors Horton, Julie K., Stefanick, Donna F., Kedar, Padmini S., Wilson, Samuel H.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 01.06.2007
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Human fibroblasts, capable of expressing a kinase-dead form of ATR (ATRkd), can be sensitized to the cytotoxic effects of methyl methanesulfonate (MMS) by the PARP inhibitor 4-amino-1,8-naphthalimide (4-AN). The combination of MMS + 4-AN results in accumulation of cells in S-phase of the cell cycle and activation of Chk1. Inhibition of ATR activity by expression of ATRkd suppresses the S-phase accumulation and partially reverses the Chk1 phosphorylation. The results confirm involvement of an ATR-mediated damage response pathway in the MMS + 4-AN-induced S-phase cell cycle checkpoint in human fibroblasts. Consistent with this hypothesis, the inhibitors caffeine and UCN-01 also abrogate the ATR- and Chk1-mediated delay in progression through S-phase. In the absence of ATR-mediated signaling, MMS + 4-AN exposure results in a G 2/M arrest, rather than an S-phase checkpoint. Thus, whereas ATR mediates the S-phase response, it is not critical for arrest of cells in G 2/M.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Tel.: +1 919 541 3267; fax: +1 919 541 3592. E-mail address: wilson5@niehs.nih.gov (S.H. Wilson).
ISSN:1568-7864
1568-7856
DOI:10.1016/j.dnarep.2006.12.015